BioAuxilium will attend the CiToxLAB/NEOMED Symposium V

BioAuxilium will be at the CiToxLAB/NEOMED Symposium “Discovery to Development Symposium V”, hosted at the National Research Council Canada. Please come and meet us for details about our services.

BioAuxilium will attend the CSPS 2014 Annual Conference

BioAuxilium will be at the 2014 Annual Conference of the Canadian Society for Pharmaceutical Sciences, hosted at the Centre Mont Royal, Montreal. To set up a meeting, please contact us (info@bioauxilium.com).

BioAuxilium will attend BIO 2014 in San Diego, USA

BioAuxilium will be at the 2014 BIO International Convention taking place in San Diego from June 23 – 26, 2014 (http://convention.bio.org/2014/). BIO is the largest global event for the biotechnology industry. This event provides insights on the major trends affecting the industry and brings together worldwide industry key players to meet and build partnerships. Come and meet us inside the Québec Pavilion, booth #1911. To set up a meeting with a BioAuxilium‘s representative, please contact us (info@bioauxilium.com).

BioAuxilium joins the NEOMED Institute

BioAuxilium moves into a start-of-the-art, fully kitted laboratory at the NEOMED Institute (http://www.neomed.ca/neomed-institute/resident-companies.html), an open access drug discovery hub located in the former AstraZeneca facility in Technoparc Montréal.

BioAuxilium reaches an industrial milestone

BioAuxilium is pleased to announce that has reached an industry milestone with the immunoanalysis of biological sample number 50,000 from the Montreal Diabetes Research Center (http://www.montreal-diabetes-research-center.org/en/).

BioAuxilium will attend SILS 2013

BioAuxilium will be attending the Sherbrooke International Life Sciences (SILS) Summit Conference on September 26 and 27, 2013 (http://sils-sherbrooke.com/).

BioAuxilium sponsors the CiToxLAB/NEOMED Symposium IV

BioAuxilium is a proud sponsor of the CiToxLAB/NEOMED Symposium “Discovery to Development Symposium IV”, hosted at the NEOMED Institute. Please come and meet us for details about our services.

BioAuxilium signs a collaborative agreement with PerkinElmer

BioAuxilium has signed an assay development collaboration with PerkinElmer. Under this agreement, BioAuxilium is now able to offer proof-of-concept assays and immunoassay development based on PerkinElmer’s “No Wash” homogenous bead-based AlphaLISA® assay technology (http://www.perkinelmer.ca/en-ca/catalog/category/id/alphatech).

BioAuxilium will attend the Global R&D 5th Annual Forum

BioAuxilium will be attending the Global R&D 5th Annual Forum organized by the CQDM and Montreal In Vivo. Please come and meet us for details about our services.